Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-10 · accession 0000899243-22-035784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-14 | 2022-11-10+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.56 | -384.0K | 21.78M | -2% | -$982.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-11 | S | D | 197,964 | $2.65 | 21,583,782 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-11-10 | S | D | 186,028 | $2.46 | 21,781,746 | D | — | — |